Precision Targeted Therapy for PCOS: Emerging Drugs, Translational Challenges, and Future Opportunities. [PDF]
Wu X, Yi W, Liu X.
europepmc +1 more source
Extended Oral Glucose Tolerance Test Unmasks Intermediate Metabolic Phenotypes in Polycystic Ovary Syndrome. [PDF]
Wang S, Gao X, Li F.
europepmc +1 more source
Total Testosterone Measured by Liquid Chromatograph-Tandem Mass Spectrometry Refines Diagnosis of Biochemical Hyperandrogenism and Better Identifies Subgroup at Genuine Risk of Adverse Fertility Outcomes in Women With Polycystic Ovary Syndrome. [PDF]
Li J +18 more
europepmc +1 more source
Possible drug reaction with eosinophilia and systemic symptoms after spironolactone therapy for clinical hyperandrogenism: a case report. [PDF]
Hoang S, Strom D, Brennan KM.
europepmc +1 more source
Exploring the Combination of Traditional Chinese and Allopathic Medicine in the Treatment of Polycystic Ovary Syndrome from the Perspective of Modern Medicine. [PDF]
Hu X +8 more
europepmc +1 more source
Divergent pathophysiological drivers of polycystic ovary syndrome: insulin resistance independently fuels the hyperandrogenic phenotype whilst neuroendocrine factors dominate non-hyperandrogenic presentations. [PDF]
Wang X +7 more
europepmc +1 more source
Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies. [PDF]
Damoulaki E +10 more
europepmc +1 more source
Computed Tomography Angiography-Assisted Ovarian Vein Sampling for Diagnosing an Androgen-Producing Leydig Cell Tumor: A Case Report. [PDF]
Tomotsune K +11 more
europepmc +1 more source
Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms. [PDF]
Badejogbin OC +7 more
europepmc +1 more source
Serum Chemerin Levels in Polish Women with PCOS-Phenotype D. [PDF]
Kuliczkowska-Płaksej J +7 more
europepmc +1 more source

